142 related articles for article (PubMed ID: 112805)
1. [Diagnostics and therapy of the carcinoma of the prostate (author's transl)].
Schnorr D; Guddat HM; Neuser D; Correns HJ; Dörner G; Mau S
Zentralbl Chir; 1979; 104(7):436-45. PubMed ID: 112805
[TBL] [Abstract][Full Text] [Related]
2. Current management of prostatic carcinoma.
Bahnson RR; Catalona WJ
Prim Care; 1985 Dec; 12(4):795-813. PubMed ID: 3909178
[TBL] [Abstract][Full Text] [Related]
3. [Orchidectomy and oestrogen therapy of carcinoma of the prostate (author's transl)].
Straube W; Braun JS
Urologe A; 1974 Jul; 13(4 Pt A):198-201. PubMed ID: 4137442
[No Abstract] [Full Text] [Related]
4. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
Mayer FJ; Crawford ED
Urol Clin North Am; 1994 Nov; 21(4):707-15. PubMed ID: 7974899
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of prostatic cytology in primary diagnosis and clinical course of prostatic carcinoma.
Bandhauer K; Spieler P; Egle N
Prog Clin Biol Res; 1976; 6():329-45. PubMed ID: 1023215
[TBL] [Abstract][Full Text] [Related]
6. [Prostatic cancer, diagnosis and hormonal treatment (author's transl)].
Rutishauser G
Schweiz Rundsch Med Prax; 1974 Feb; 63(5):120-3. PubMed ID: 4424280
[No Abstract] [Full Text] [Related]
7. [Transretcat aspiration biopsy in the diagnosis of prostatic cancer (author's transl)].
Droese M; Soost HJ; Voeth C
Urologe A; 1976 Jan; 15(1):13-7. PubMed ID: 1258227
[TBL] [Abstract][Full Text] [Related]
8. Management of newly diagnosed metastatic carcinoma of the prostate.
Elder JS; Catalona WJ
Urol Clin North Am; 1984 May; 11(2):283-95. PubMed ID: 6428022
[TBL] [Abstract][Full Text] [Related]
9. Treatment of stage IV carcinoma of the prostate.
Resnick MI; Grayhack JT
Urol Clin North Am; 1975 Feb; 2(1):141-61. PubMed ID: 1093057
[TBL] [Abstract][Full Text] [Related]
10. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic and treatment of prostatic cancer (author's transl)].
Schnorr D; Guddat HM; Lenk S
Zentralbl Chir; 1977; 102(6):326-31. PubMed ID: 405821
[TBL] [Abstract][Full Text] [Related]
12. Population based study of hormonal therapy and survival in men with metastatic prostate cancer.
Lu-Yao G; Moore DF; Oleynick JU; DiPaola RS; Yao SL
J Urol; 2007 Feb; 177(2):535-9. PubMed ID: 17222628
[TBL] [Abstract][Full Text] [Related]
13. Combination of hormonal and cytostatic treatment for advanced carcinoma of the prostate.
Servadio C
Prog Clin Biol Res; 1985; 185A():407-26. PubMed ID: 4034582
[No Abstract] [Full Text] [Related]
14. [A study of transrectal aspiration biopsy of the prostate].
Fujioka T; Ishii N; Chiba R; Majima K; Numata I; Hakozaki H
Hinyokika Kiyo; 1984 Sep; 30(9):1189-94. PubMed ID: 6524561
[TBL] [Abstract][Full Text] [Related]
15. [Treatment and prognosis of prostate carcinoma. Actual standing (author's transl)].
Heising J; Allhoff E
Z Hautkr; 1981 Jun; 56(11):705-14. PubMed ID: 6167082
[TBL] [Abstract][Full Text] [Related]
16. [Regression and disappearance of bone metastasis in a case of prostatic carcinoma after bilateral orchidectomy and oestrogen therapy (author's transl)].
Suhler A
J Urol (Paris); 1981; 87(4):227-9. PubMed ID: 7264352
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas.
Stege R; Grande M; Carlström K; Tribukait B; Pousette A
Clin Cancer Res; 2000 Jan; 6(1):160-5. PubMed ID: 10656445
[TBL] [Abstract][Full Text] [Related]
18. The magnitude of early castration-induced primary tumour regression in prostate cancer does not predict clinical outcome.
Ohlson N; Bergh A; Nygren K; Stattin P; Wikström P
Eur Urol; 2006 Apr; 49(4):675-83. PubMed ID: 16387414
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of cytomorphological parameters during hormonal therapy of prostatic carcinoma (author's transl)].
Keller AJ; Völter D; Bertsch H
Urologe A; 1981 Jul; 20(4):228-30. PubMed ID: 7196633
[TBL] [Abstract][Full Text] [Related]
20. [Treatment results of combined hormone and chemotherapy in patients with advanced prostate cancer].
Uekado Y
Hinyokika Kiyo; 1991 Aug; 37(8):825-31. PubMed ID: 1957724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
